| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO and President
1 company
Rami Levin is CEO and President at CNSP. Rami Levin's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $22K at current prices.
Rami Levin has 2 Form 4 filings on record from January 2026 to August 2026, all as CEO and President at CNS Pharmaceuticals (CNSP), 2026.
The 2 reported transactions were 1 option exercise and 1 option or other derivative award.
There are no priced open-market purchases or sales on record, so none of these filings shows a decision to buy or sell shares in the market.
No transactions found
Try adjusting your filters or search criteria